Company intelligence / Profile preview

Heracure Medical

Ownership: Private
Development stage: Preclinical

Overview

Heracure Medical developed an innovative control system and medical instruments designed to enable safer and faster removal of large uteri and selective mechanical resection of fibroids via a vaginal approach, offering a less invasive alternative to traditional abdominal surgery. The company was dissolved voluntarily and is no longer active; there are no public clinical results or commercial products reported.

Therapeutic areas: Women's Health
Modalities: Device (specifically, surgical instrument for gynecological procedures)
Industry: Surgical Medical Devices

Beyond the preview

Go deeper on Heracure Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Heracure Medical.

Explore the full profile